Optimal Blood Pressure Management in Hypertensive Emergencies

Please Note: This CME activity has expired. You may continue to view the material for educational purposes, but this activity is no longer eligible for CME credit.

Course Objectives:
This CME-certified monograph is intended for bone marrow transplant surgeons, hematology-oncology physicians, and infectious disease specialists.

Upon completing this activity, you should be able to:

• Discuss current management strategies for blood pressure control in acute intracerebral and subarachnoid hemorrhage.
• Discuss current management strategies for blood pressure control in ischemic stroke.
• Discuss current management strategies for blood pressure control in acute hypertension associated with aortic aneurysm surgery.

Accreditation:
Millennium CME Institute, Inc. proudly acknowledges its academic partnership with the UMDNJ—Center for Continuing and Outreach Education in the development of this activity and in the review of the educational content. Millennium CME Institute, Inc. has assumed the responsibility for long-term retention of individual credit records.

Millennium CME Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Millennium CME Institute, Inc. designates this educational activity for a maximum of .75 Category 1 Credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

This activity was prepared in accordance with the ACCME Essentials.

This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Adnan Qureshi, MD and Navin Verma, MD.

Release Date: March 2006

Expiration Date: March 31, 2007

© 2006 Millennium CME Institute, Inc. and UMDNJ—Center for Continuing and Outreach Education

Faculty Disclosure:
Millennium CME Institute, Inc., endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support. All faculty are required to disclose any commercial relationships or personal benefit with companies whose products are discussed in educational presentations and with companies who have provided the commercial support for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

The faculty listed below have declared that they have no relationships to disclose:

• David C. Howard
• Adnan Qureshi, MD
• Tim Robinson
• John Warren

The faculty listed below have declared the following arrangements and/or affiliations:
Mark J. Alberts, MD: Speaker/Honoraria—ESP Pharma

Signed Disclosure forms are on file at Millennium CME Institute, Inc.

The opinions expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of PDL BioPharma, any other manufacturer of pharmaceuticals, the University of Medicine & Dentistry of New Jersey (UMDNJ), or Millennium CME Institute, Inc. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.

This Critical Care Express Report^TM is supported by an educational grant from PDL BioPharma.

This CME-certified monograph contains information of commercial products/ devices that are unlabeled for use or investigational uses of products not yet approved.

Directions:
The learner should read the learning objectives and review the activity in its entirety. After reviewing the material, the learner should complete the Activity Self-assessment Test consisting of a series of multiple-choice questions.

Upon successfully completing this activity as designed and achieving a passing score of 70% or higher on the Activity Self-assessment Test, participants will receive a continuing education credit letter awarding the appropriate credit and the Activity Self-assessment Test answers four to six weeks after the receipt of the registration and evaluation materials.

Estimated time to complete this activity as designed is 1.5 hours.

CME Testing Options